Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 39

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Deferasirox-induced renal impairment in children: an increasing concern for pediatricians

Dubourg, Laurence, Laurain, Céline, Ranchin, Bruno, Pondarré, Corinne, Hadj-Aïssa, Aoumeur, Sigaudo-Roussel, Dominique, Cochat, Pierre · 2012 · Pediatric Nephrology

Abstract

Background Deferasirox (DFX) is an oral iron chelator with an established dose-dependent efficacy in transfusion-related iron overload. Whereas emerging long-term data confirm the safety of the drug, with transient moderate elevation of serum creatinine level, several authors have reported renal tubular dysfunction. The aim of this study was to evaluate tubular and glomerular function before and after the initiation of DFX therapy in a pediatric patient population. Methods Ten children (4 girls, mean age 12.4 ± 3.9 years) enrolled in a routine blood transfusion program were treated with 24.8 ± 9.6 mg/kg per day of DFX, and renal function was assessed before and 17.2 ± 8.9 months after the initiation of DFX therapy. Results Prior to treatment with DFX, all patients had a normal glomerular function rate (GFR) (125 ± 15 ml/min per 1.73 m(2)) and normal tubular function. Following the initiation of DFX therapy, the GFR decreased by approximately 20 % with one patient with a GFR of Conclusions Renal toxicity is a frequent adverse event of DFX treatment, presenting as both glomerular and proximal dysfunction. A routine renal assessment is therefore required to prevent chronic kidney disease that may result from prolonged tubular injury.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00467-012-2170-4

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Cited by

See all 39

Metadata

Authors
Dubourg, L., Laurain, C., Ranchin, B., Pondarré, C., Hadj-Aïssa, A., Sigaudo-Roussel, D., & Cochat, P.
Venue
Pediatric Nephrology
Published
2012-04-24
Volume
27
Issue
11
Pages
2115-2122
ISSN
  • 0931-041X
  • 1432-198X
Cited by
39
References
41
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deferasirox-induced renal impairment in children: an increasing concern for pediatricians. https://app.cochat.ai/papers/10.1007/s00467-012-2170-4
The paper
Dubourg, L., Laurain, C., Ranchin, B., Pondarré, C., Hadj-Aïssa, A., Sigaudo-Roussel, D., & Cochat, P. (2012). Deferasirox-induced renal impairment in children: an increasing concern for pediatricians. Pediatric Nephrology. https://doi.org/10.1007/s00467-012-2170-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.